Received: 10 January 2021
Accepted: 3 September 2021
First Online: 13 September 2021
: M.U. contributed to this Article as an employee of Mount Sinai and the views expressed do not necessarily represent the views of Regeneron Pharmaceuticals. F.D.P. is a member of the Scientific Board of Pharmextracta, the vendor of Quevir, a dietary supplement containing quercetin in a sunflower lecithin formulation. The laboratory of A.G.-S. has received research support from Pfizer, Senhwa Biosciences, Kenall Manufacturing, Avimex, Johnson & Johnson, Dynavax, 7Hills Pharma, Pharmamar, ImmunityBio, Accurius, Nanocomposix, and Merck. A.G.-S. has consulting agreements with the following companies involving cash and/or stock: Vivaldi Biosciences, Contrafect, 7Hills Pharma, Avimex, Vaxalto, Pagoda, Accurius, Esperovax, Farmak, and Pfizer. A.G.-S. is an inventor on patents and patent applications on the use of antivirals and vaccines for the treatment and prevention of virus infections owned by the Icahn School of Medicine at Mount Sinai, New York. C.A.S. received travel support, honoraria and consulting fees from Abbvie, AstraZeneca, Bayer, Bristol-Myers Squibb/Celgene, Gilead/Kite, Janssen-Cilag, MSD, Novartis, Octapharma, Pierre Fabre, Roche, Sanofi, Takeda and TissUse.
Free to read: This content has been made available to all.